Year: 2014
Type: review
Abstract: Leishmania spp. are intracellular parasitic protozoa responsible for a group of neglected tropical diseases, endemic in 98 countries around the world, called leishmaniasis. These parasites have a complex digenetic life cycle requiring a susceptible vertebrate host and a permissive insect vector, which allow their transmission. The clinical manifestations associated with leishmaniasis depend on complex interactions between the parasite and the host immune system. Consequently, leishmaniasis can be manifested as a self-healing cutaneous affliction or a visceral pathology, being the last one fatal in 85-90% of untreated cases. As a result of a long host-parasite co-evolutionary process, Leishmania spp. developed different immunomodulatory strategies that are essential for the establishment of infection. Only through deception and manipulation of the immune system, Leishmania spp. can complete its life cycle and survive. The understanding of the mechanisms associated with immune evasion and disease progression is essential for the development of novel therapies and vaccine approaches. Here, we revise how the parasite manipulates cell death and immune responses to survive and thrive in the shadow of the immune system.
Source: Frontiers in Immunology
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Awards: THE ROLE OF SIRTUINS IN THE MODULATION OF ANTIGEN PRESENTING CELL DEATH DURING VISCERAL LEISHMANIASIS, G1578237752, Kinetoplastid Drug Development: strengthening the preclinical pipeline, Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis, Comunicação celular por microvesículas de Leishmania, G8868700560, G8952488736
OpenAlex ID: W1683978517
